LA JOLLA — Scientists at the Salk Institute have uncovered a molecule whose mutation leads to the aggressive growth of a common and
deadly type of lung cancer in humans.
Not exact matches
Pharmaceutical giant Merck's flagship immunotherapy drug that was just approved by the United States Food and Drug Administration (FDA) shows promise in the overall survival rate among patients suffering from one
of the
deadliest type of cancer that affects the
lungs.
The FDA approved a new drug to treat one
of the most common and
deadliest cancer types -
lung cancer.